http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101435951-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185 |
| filingDate | 2013-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101435951-B1 |
| titleOfInvention | Pharmaceutical composition for treating or preventing hepatitis C comprising 4-phenylbutyric acid |
| abstract | The present invention provides a pharmaceutical composition for the treatment or prevention of hepatitis C comprising 4-phenylbutyric acid or a pharmaceutically acceptable salt thereof. The pharmaceutical composition according to the present invention can be effectively used for the treatment or prevention of hepatitis C because it has excellent HCV inhibitory effect, low toxicity, and can be applied to interferon-resistant patients. |
| priorityDate | 2013-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.